(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

57 API Suppliers, 9 USDMF, 9 CEP/COS, 14 JDMF, 5 EU WC, 6 KDMF, 6 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

FINISHED DOSAGE FORMULATIONS

323 FDF Dossiers, 20 FDA Orange Book, 53 Europe, 9 Canada, 65 South Africa, 176 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML), SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 Evonik, 14 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 26 DKSH, 2 Pharm-RX Chemical, 11 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 2 Kewpie Corporation, 13 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 16 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 36 BASF, 2 Bioplus Life Sciences, 2 Clariant, 13 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 13 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 34 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 22 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 13 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 39 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

119 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 51 Thickeners and Stabilizers, 50 Direct Compression, 45 Taste Masking, 43 Solubilizers, 40 Parenteral, 38 Controlled & Modified Release, 34 Disintegrants & Superdisintegrants, 32 Granulation, 31 Topical, 30 Film Formers & Plasticizers, 25 Lubricants & Glidants, 23 Chewable & Orodispersible Aids, 22 Co-Processed Excipients, 16 Emulsifying Agents, 13 Rheology Modifiers, 11 API Stability Enhancers, 9 Empty Capsules, 7 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 27 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 28 Finished Drug Prices

MARKET PLACE

176 APIs, 34 FDF Dossiers, 13 EXCIPIENTS

PATENTS & EXCLUSIVITIES

13 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

5 EDQM, 2 USP, 3 JP, 6 Others

ANALYTICAL

11 Analytical Methods

11 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21625 / DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

Inactive Ingredients

Ingredient Name	Hospira, Inc.
BUTYLATED HYDROXYANISOLE(REK4960K2U)
BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
GENTISIC ACID ETHANOLAMIDE(H4E039OIGX)
POLYSORBATE 20(7T1F30V5YH)
POLYSORBATE 80(6OZP39ZG8H)
PROPYLENE GLYCOL(6DC9Q167V3)
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)
SODIUM HYDROXIDE(55X04QC32I)

Drug Product Composition: (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one